WEST LAFAYETTE, Ind., Aug. 6, 2013 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company and leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging diagnostics for personalized therapy in cancer and other serious diseases, today announced the company's management team will present at the Wedbush 2013 Life Sciences Management Access Conference on Tuesday, Aug. 13, at 8 a.m. The conference is being held in New York.